Business
ASX 200 to rise after positive AstraZeneca COVID-19 vaccine news
It looks set to be another positive day of trade for the S&P/ASX 200 Index (ASX: XJO) on Tuesday after a third COVID-19 vaccine candidate was shown to be effective.
At the time of writing, SPI futures are pointing to the ASX opening the day 31 points or 0.5% higher this morning.
What is the new vaccine candidate?
Overnight British pharmaceutical giant AstraZeneca revealed that data from an interim analysis of clinical trials showed that its vaccine, AZD1222, had an average efficacy of 70% in protecting against COVID-19.
This follows recent updates by both Pfizer and Moderna which showed that their vaccines are 95% effective against the virus.
While 70% might not sound amazing, it is worth noting that the AstraZeneca vaccine,…
-
Noosa News17 hours agoMeet Chad Burgess, Pauline Hanson’s One Nation Party
-
Noosa News24 hours agoScenic Rim council cracks down on farmers hosting campers without a permit
-
Noosa News18 hours agoWestern Queensland graziers begin grim stock count after catastrophic floods
-
Noosa News19 hours agoHelicopter scrambles to site of air crash on K’gari